Drug Information

Drug General Information
Drug ID
D0L1HK
Former ID
DNCL003285
Drug Name
TCN-032
Drug Type
Antibody
Indication Influenza virus [ICD10:J11.1] Phase 2 [524110]
Company
Theraclone Sciences
Target and Pathway
Target(s) Influenza A virus M2 protein Target Info [544135]
WikiPathways Influenza Life Cycle
References
Ref 524110ClinicalTrials.gov (NCT01719874) Influenza Virus Challenge Study to Test Monoclonal Antibody TCN-032 as a Treatment for Influenza. U.S. National Institutes of Health.
Ref 544135Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A viruses. Proc Natl Acad Sci U S A. 2010 July 13; 107(28): 12658-12663.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.